This is an early safety study testing a new oral medication called ENV-294 for adults with moderate-to-severe atopic dermatitis (eczema). The main goal is to see if the drug is safe and well-tolerated when taken daily for 28 days. Researchers will also check if it helps reduce ec…
Phase: PHASE1 • Sponsor: Enveda Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC